You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

ID: 4-5 juin 2016
Type of Content: Guidelines & Advice, Clinical
Document Status: In-Review
Authors:
H. Lukka, H. Hirte, A. Fyles, G. Thomas, M. Fung Kee Fung, M. Johnston , Gynecology Cancer Disease Site Group

Patient Population

Women with cervical cancer for whom primary treatment with radiotherapy is being considered:

  • Those with locally advanced cervical cancer
  • Those with bulky clinical stage IB (>4 cm) cervical cancer, who are treated with radiotherapy
  • Those with high-risk early-stage cervical cancer (node-positive or margin-positive), who will be treated with radiotherapy following hysterectomy

Research Question(s)

For women with cervical cancer in whom radiotherapy is considered appropriate, does the addition of concurrent platinum-based chemotherapy improve survival and quality of life with acceptable toxicity?

pdf download Summary (PDF) (311.01 Ko)
pdf download Full Report (PDF) (937.66 Ko)